Related Experiment Video

Updated: Aug 5, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

[Relation between fetal intrauterine growth retardation and anticardiolipin antibodies]

Z Wang1, Y Fan, G Wu

  • 1Chang Zhou Obstetric and Gynecologic Hospital, Changzhou.

Zhonghua Fu Chan Ke Za Zhi
|June 27, 1998
PubMed

Insights

Anticardiolipin antibodies (ACA) are linked to increased risk of intrauterine growth retardation (IUGR). Detecting ACA may aid in diagnosing and treating IUGR in pregnant individuals.

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Perinatology

Context:

  • Intrauterine growth retardation (IUGR) is a significant concern in prenatal care.
  • Anticardiolipin antibodies (ACA) are autoantibodies associated with thrombotic events and pregnancy complications.

Purpose:

  • To examine the association between anticardiolipin antibodies and fetal intrauterine growth retardation.
  • To evaluate the diagnostic and therapeutic implications of ACA detection in IUGR.

Summary:

  • A study of 5,330 normal pregnancies found a 2.70% positive rate for ACA.
  • The incidence of IUGR was significantly higher (15.28%) in pregnancies with positive ACA compared to those with negative ACA (1.77%).
  • Immunocomplex depositions were observed in placentas of IUGR cases with positive ACA.

Impact:

  • Anticardiolipin antibodies are identified as a potential causative factor for IUGR.
  • Serum ACA determination offers a novel approach for the diagnosis and management of IUGR.
  • This research highlights the importance of immunological markers in understanding and addressing fetal growth restriction.
Abstract

More Related Videos

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment08:53

Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment

Published on: March 24, 2026

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...